论文部分内容阅读
目的:对布地奈德雾化吸入作为辅助方式治疗小儿支气管肺炎的临床效果进行评价。方法:将2015年3月-2016年1月收治的386例患有小儿支气管肺炎患儿随机将其分为对照组与观察组,每组193例。单纯用采常规临床治疗方法的为对照组,采取常规临床治疗方法治疗小儿支气管肺炎加布地奈德雾化吸入辅助治疗为观察组,8 d后将两组的观察结果与治疗结果进行对比并评价。结果:观察组的总有效率比对照组明显增大,差异具有统计学意义(P<0.05),观察组的临床数据同对照组相比都明显的缩短,差异具有统计学意义(P<0.05)。结论:常规临床治疗方法 +布地奈德雾化吸入治疗小儿支气管肺炎具有较好的效果。
OBJECTIVE: To evaluate the clinical efficacy of inhaled budesonide as an adjunct to treat bronchial pneumonia in children. Methods: 386 children with bronchial pneumonia admitted from March 2015 to January 2016 were randomly divided into control group and observation group, with 193 cases in each group. Using routine clinical treatment as a control group, taking routine clinical treatment of bronchial pneumonia in patients with bronchial pneumonia and budesonide aerosol inhalation adjuvant therapy for the observation group, 8 d after the two groups of observations and treatment results were compared and evaluated . Results: The total effective rate in the observation group was significantly higher than that in the control group (P <0.05), and the clinical data in the observation group were significantly shortened compared with the control group (P <0.05 ). Conclusion: The conventional clinical treatment + Budesonide inhalation therapy for children with bronchopneumonia has a good effect.